Answers are grounded in this paper and cite their sources.
This letter indicates that in a patient with long-standing dense-deposit disease, a variant of membranoproliferative glomerulonephritis, eculizumab can be useful in the resolution of the nephrotic syndrome.
No takes yet. Share an insight, caveat, or question.
Daina et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: